Multidimensional Fatigue Inventory in People With Hepatitis B Infection: Cross-cultural Adaptation and Psychometric

Mohsen Saffari1, Maryam K Naderi, Crystal N Piper

  • 1Mohsen Saffari, PhD, is Associate Professor, Health Research Center, and Health Education Department, Faculty of Health, Baqiyatallah University of Medical Sciences, Tehran, Iran. Maryam K. Naderi, MSc, is Student, Health Education Department, Faculty of Health, Baqiyatallah University of Medical Sciences, Tehran, Iran. Crystal N. Piper, PhD, is Associate Professor, Department of Public Health Sciences, College of Health and Human Services, University of North Carolina at Charlotte, Charlotte. Harold G. Koenig, MD, is Professor, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina; Distinguished Adjunct Professor, King Abdulaziz University, Jeddah, Saudi Arabia; Adjunct Professor of Public Health, Ningxia Medical University, Yinchuan, China.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
225
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
272
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
299